RSV study aims to unlock immune secrets in older adults
NCT ID NCT03728413
First seen Feb 01, 2026 · Last updated Apr 28, 2026 · Updated 9 times
Summary
This study looked at how the immune system of older adults (ages 60-75) responds to the respiratory syncytial virus (RSV). Researchers exposed 28 healthy volunteers to a controlled dose of RSV to measure their immune reactions and track any side effects. The goal is to find better targets for vaccines that work well in older people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College London
London, W12 0NN, United Kingdom
Conditions
Explore the condition pages connected to this study.